Metabolic Flux Increases Glycoprotein Sialylation: Implications for Cell Adhesion and Cancer Metastasis*

This study reports a global glycoproteomic analysis of pancreatic cancer cells that describes how flux through the sialic acid biosynthetic pathway selectively modulates a subset of N-glycosylation sites found within cellular proteins. These results provide evidence that sialoglycoprotein patterns are not determined exclusively by the transcription of biosynthetic enzymes or the availability of N-glycan sequons; instead, bulk metabolic flux through the sialic acid pathway has a remarkable ability to increase the abundance of certain sialoglycoproteins while having a minimal impact on others. Specifically, of 82 glycoproteins identified through a mass spectrometry and bioinformatics approach, ∼31% showed no change in sialylation, ∼29% exhibited a modest increase, whereas ∼40% experienced an increase of greater than twofold. Increased sialylation of specific glycoproteins resulted in changes to the adhesive properties of SW1990 pancreatic cancer cells (e.g. increased CD44-mediated adhesion to selectins under physiological flow and enhanced integrin-mediated cell mobility on collagen and fibronectin). These results indicate that cancer cells can become more aggressively malignant by controlling the sialylation of proteins implicated in metastatic transformation via metabolic flux.

[1]  A. Mariotti,et al.  [The sialic acids]. , 1960, Minerva medica.

[2]  S. Roseman,et al.  The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. , 1971, The Journal of biological chemistry.

[3]  R K Craig,et al.  Methods in molecular medicine. , 1987, British medical journal.

[4]  T. A. Fritz,et al.  Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Simon,et al.  The α6-integrin receptor in pancreatic carcinoma☆ , 1995 .

[6]  C. Goochee,et al.  A mathematical model of sialylation of N-linked oligosaccharides in the trans-Golgi network. , 1997, Glycobiology.

[7]  R. Kannagi,et al.  Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells , 1998, Journal of surgical oncology.

[8]  M. Pawlita,et al.  UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. , 1999, Science.

[9]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[10]  K. Konstantopoulos,et al.  Glycolipids support E-selectin-specific strong cell tethering under flow. , 2001, Biochemical and biophysical research communications.

[11]  C. Bertozzi,et al.  Metabolic selection of glycosylation defects in human cells , 2001, Nature Biotechnology.

[12]  C. Bertozzi,et al.  Substrate specificity of the sialic acid biosynthetic pathway. , 2001, Biochemistry.

[13]  Ruedi Aebersold,et al.  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.

[14]  J. Takagi,et al.  Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Mark B. Jones,et al.  Characterization of the cellular uptake and metabolic conversion of acetylated N‐acetylmannosamine (ManNAc) analogues to sialic acids , 2004, Biotechnology and bioengineering.

[16]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[17]  Alan J Wright,et al.  Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. , 2004, Molecular cell.

[18]  Mark B. Jones,et al.  Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells* , 2004, Journal of Biological Chemistry.

[19]  Claus-Wilhelm von der Lieth,et al.  GlyProt: in silico glycosylation of proteins , 2005, Nucleic Acids Res..

[20]  J. Wakefield,et al.  Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. , 2005, Cancer research.

[21]  K. Konstantopoulos,et al.  Variant isoforms of CD44 are P‐ and L‐selectin ligands on colon carcinoma cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Y. Wada,et al.  N-Glycosylation of the β-Propeller Domain of the Integrin α5 Subunit Is Essential for α5β1 Heterodimerization, Expression on the Cell Surface, and Its Biological Function* , 2006, Journal of Biological Chemistry.

[23]  ROLES FOR GNE OUTSIDE OF SIALIC ACID BIOSYNTHESIS : MODULATION OF SIALYLTRANSFERASE AND BiP EXPRESSION , GM 3 AND GD 3 BIOSYNTHESIS , PROLIFERATION AND APOPTOSIS , AND ERK 1 / 2 PHOSPHORYLATION , 2006 .

[24]  P. Tonali,et al.  NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations , 2006, Neurology.

[25]  K. Yarema,et al.  Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis , 2006, Journal of Biological Chemistry.

[26]  Julia T. Chu,et al.  HCELL Is the Major E- and L-selectin Ligand Expressed on LS174T Colon Carcinoma Cells* , 2006, Journal of Biological Chemistry.

[27]  R. Aebersold,et al.  Isolation of glycoproteins and identification of their N-linked glycosylation sites. , 2006, Methods in molecular biology.

[28]  Yuan Tian,et al.  Solid-phase extraction of N-linked glycopeptides , 2007, Nature Protocols.

[29]  J. Dennis,et al.  Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and Differentiation , 2007, Cell.

[30]  K. Yarema,et al.  Metabolic oligosaccharide engineering: perspectives, applications, and future directions. , 2007, Molecular bioSystems.

[31]  O. Florey,et al.  Analysis of flow-based adhesion in vitro. , 2007, Methods in molecular medicine.

[32]  K. Konstantopoulos,et al.  Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells , 2006, Journal of Biological Chemistry.

[33]  B. Galeano,et al.  Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. , 2007, The Journal of clinical investigation.

[34]  Udayanath Aich,et al.  Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. , 2008, Journal of medicinal chemistry.

[35]  Ken S Lau,et al.  N-Glycans in cancer progression. , 2008, Glycobiology.

[36]  D. MacArthur,et al.  UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) Binds to Alpha-Actinin 1: Novel Pathways in Skeletal Muscle? , 2008, PloS one.

[37]  K. Konstantopoulos,et al.  Carcinoembryonic Antigen and CD44 Variant Isoforms Cooperate to Mediate Colon Carcinoma Cell Adhesion to E- and L-selectin in Shear Flow* , 2008, Journal of Biological Chemistry.

[38]  Udayanath Aich,et al.  Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression. , 2008, ACS chemical biology.

[39]  Raja R Srinivas,et al.  Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. , 2009, Journal of medicinal chemistry.

[40]  M. A. Meledeo,et al.  Hexosamine analogs: from metabolic glycoengineering to drug discovery. , 2009, Current opinion in chemical biology.

[41]  J. Dennis,et al.  Metabolism, Cell Surface Organization, and Disease , 2009, Cell.

[42]  F. J. Krambeck,et al.  A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data. , 2009, Glycobiology.

[43]  Jian Du,et al.  Metabolic glycoengineering: sialic acid and beyond. , 2009, Glycobiology.

[44]  C. Hackenberger,et al.  Efficient metabolic oligosaccharide engineering of glycoproteins by UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) knock-down. , 2011, Molecular bioSystems.

[45]  Cécile Boscher,et al.  Glycosylation, galectins and cellular signaling. , 2011, Current opinion in cell biology.

[46]  Udayanath Aich,et al.  Metabolic oligosaccharide engineering with N‐Acyl functionalized ManNAc analogs: Cytotoxicity, metabolic flux, and glycan‐display considerations , 2012, Biotechnology and bioengineering.

[47]  Yuan Tian,et al.  Altered Expression of Sialylated Glycoproteins in Breast Cancer Using Hydrazide Chemistry and Mass Spectrometry* , 2012, Molecular & Cellular Proteomics.